期刊文献+

头孢硫脒在小鼠的药动学研究 被引量:1

The pharmacokinetics study of cefathiamidine in mice
下载PDF
导出
摘要 目的 研究头孢硫脒在小鼠中的药动学.方法 取24只小鼠,随机分为4组,每组6只,分别静脉给予7.3、29.2、116.8和467.6mg/kg的头孢硫脒,采集不同时间点的血样,分离血浆,使用经过确证的LC-MS/MS方法测定血浆中头孢硫脒的浓度,用WinNonlin软件中的非房室模型计算药动学参数.结果 静脉给药后,获得的主要药动学参数如下:T1/2分别为(0.20±0.03)、(0.33±0.05)、(0.27±0.08)和(0.38±0.10)h;AUC0~∞分别为(2.85±0.63)、(11.31±1.71)、(53.38±17.57)和(374.9±134.7)h·mg/L;Cax值分别为(9.53±2.10)、(46.67±9.50)、(170.18±71.02)和(1004.0±166.2)mg/L.结论 本文建立了快速、灵敏测定小鼠血浆中头孢硫脒的LC-MS/MS方法,并用于头孢硫脒在小鼠中的药动学研究.药动学结果显示,该药体内消除很快,不同剂量间的药动学参数呈现比较明显的相关关系. Objective To investigate the pharmacokinetics of cefathiamidine in mice. Methods 24 mice were randomly divided into four groups (n=6), blood samples were collected at different time intervals following intravenous injection of cefathiamidine at one of the four doses (7.3, 29.2, 116.8 and 467.6mg/kg). The cefathiamidine concentrations in mice plasma were determined by a validated LC-MS/MS method and the pharmacokinetic parameters were calculated by using WinNonlin software program with non-compartmental model. Results The main pharmacokinetic parameters after intravenous injection of cefathiamidine were as follows: T1/2 were (0.20±0.03), (0.33±0.05), (0.27±0.08) and (0.38±0.10)h respectively. AUC0~∞ were (2.85±0.63) , (11.31±1.71) , (53.38±17.57) and (374.9±134.7)h.mg/L, respectively. Cax were (9.53±2.10), (46.67±9.50), 070.18±71.02) and (1004.0±166.2) mg/L respectively. Conclusion The established LC-MS/MS method for the determination of cefathiamidine in mice plasma was rapid and sensitive, and was applied to the pharmacokinetic study of cefathiamidine in mice. The pharmacokinetic results showed that the drug was eliminated fast and the pharmacokinetic parameters among different doses correlated well with each other.
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2015年第5期363-368,共6页 Chinese Journal of Antibiotics
关键词 头孢硫脒 药动学 LC-MS/MS 血浆 Cefathiamidine Pharmacokinetics LC-MS/MS Plasma
  • 相关文献

参考文献12

二级参考文献43

  • 1何汉林,邓厚明.头孢硫脒治疗肺部感染30例[J].白云医药,2003(4):5-6. 被引量:1
  • 2李忠思,张小娜,陈方,鲁澄宇,许卫铭,吴铁,揭新明.HPLC法测定头孢硫脒大鼠体内分布浓度及其药动学研究[J].中国抗生素杂志,2005,30(10):611-616. 被引量:15
  • 3崔皖芳 汪莹 包明红.头孢硫脒治疗呼吸道感染疗效观察.中国抗生素杂志,2005,28(4):254-254.
  • 4Fokkens W, Lund V, Mullol J, et al. European position paper on rhinosinusitis and nasal polyps, 2007 [ J ]. Rhinol Suppl, 2007,20 : 1.
  • 5Hospital Acquired Pneumonia Guideline committee of the American Thoracic society and Infections Diseased society of America, Guidelines for the management of adults with hospital - acquired, Ventilator - associated, and heahhcare- associated pneumonia [ J ]. Am J Respir Crit Care Med, 2005, 171(4) :388.
  • 6Desrosiers M, Ferguson B, Klossek JM, et al. clinical efficacy and time to symptom resolution of 5 - day telithromycin versus 10 - day amoxicillin - clavulanate in the treatment of acute bacterial sinusitis [ J] .Curr Med Res Opin, 2008, 24(6) :1 691.
  • 7Falagas ME, Karageorgopoulos DE, Grammatikos AP, et al, Effectiveness and safety of short vs long duration of antibiotic therapy for acute bacterial sinusitis: a meta - analysis of randomized trials [ J]. Br J Clin Pharmacal, 2009, 67(2) :161.
  • 8曾衍霖 江乃雄 倪素元.药物代谢动力学研究(Ⅰ)硫脒头孢菌素[J].药学学报,1979,14(10):587-587.
  • 9黄民 曾桂雄 黄丽慧.头孢硫脒注射液的人体药代动力学及绝对生物利用度研究[J].中国抗生素杂志,2003,28(4):253-253.
  • 10戴自英 汪复 张志林.硫脒头孢菌素的实验和临床研究[J].上海医学,1979,(9):32-32.

共引文献36

同被引文献19

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部